Mutations in the IDH genes lead to a specific hypermethylation phenotype known as the glioma CpG island methylator phenotype (G-CIMP), which is associated with better prognosis and survival (Christensen et al., 2011). The gene discussed is IDH2; the disease is central nervous system cancer.